Finasteride
Product Images NDC 58517-200

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 58517-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by New Horizon Rx Group, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description: Finasteride Structure (17f863dd Figure 01)

Chemical structure of Finasteride, depicting its specific molecular arrangement with rings, functional groups, and chemical bonds as shown in the image.*

FDA Label Image

Description: Figure 1 (17f863dd Figure 02)

A line graph depicting the mean change from baseline plus one standard error over a four-year period for two groups: Placebo and Finasteride. The x-axis represents time from baseline through Year 4, while the y-axis shows mean change values ranging approximately from 0 to -6. The Finasteride group shows a progressively greater negative mean change compared to the Placebo group over time. The sample sizes for each year are noted for both groups.*

FDA Label Image

Description: Figure 2 (17f863dd Figure 03)

A line graph comparing cumulative percent of patients over observation time (months) between Finasteride and placebo groups, showing higher values for the placebo group. Below the graph is a data table listing the number of events and patients at risk per year for both placebo and Finasteride groups over the study period.*

FDA Label Image

Description: Figure 3 (17f863dd Figure 04)

Line graph depicting the mean percent change from baseline over four years for two groups: Placebo and Finasteride. The y-axis shows percent change with error bars, while the x-axis represents time points from baseline to year 4. Placebo group data points show a negative trend, and Finasteride group data points show a positive trend.*

FDA Label Image

17f863dd-figure-05 (17f863dd Figure 05)

Finasteride 5 mg tablets, USP, in a bottle label showing 30 tablets. The label includes the NDC number 58517-200-30, the New Horizon Rx Group LLC logo, and indicates the product is prescription only. It lists manufacturer and distributor details as well as storage and usage warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.